Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.
about
Antibiotics for treating community acquired pneumonia in people with sickle cell diseaseAntibiotics for treating community acquired pneumonia in people with sickle cell diseaseMutations and polymorphisms in hemoglobin genes and the risk of pulmonary hypertension and death in sickle cell diseaseThe critical roles of platelet activation and reduced NO bioavailability in fatal pulmonary arterial hypertension in a murine hemolysis modelElevated tricuspid regurgitation velocity and decline in exercise capacity over 22 months of follow up in children and adolescents with sickle cell anemia.Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes.Sickle erythrocytes and platelets augment lung leukotriene synthesis with downregulation of anti-inflammatory proteins: relevance in the pathology of the acute chest syndrome.Doppler-defined pulmonary hypertension and the risk of death in children with sickle cell disease followed for a mean of three years.Evolution of novel small-molecule therapeutics targeting sickle cell vasculopathy.Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directionsEchocardiographic markers of elevated pulmonary pressure and left ventricular diastolic dysfunction are associated with exercise intolerance in adults and adolescents with homozygous sickle cell anemia in the United States and United Kingdom.Nitric oxide and arginine dysregulation: a novel pathway to pulmonary hypertension in hemolytic disordersHemolysis in sickle cell mice causes pulmonary hypertension due to global impairment in nitric oxide bioavailabilityPlatelet activation in patients with sickle disease, hemolysis-associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobinSildenafil in the treatment of pulmonary hypertension.Pulmonary hypertension in sickle cell disease: relevance to children.Hemodynamic and functional assessment of patients with sickle cell disease and pulmonary hypertension.Cardiopulmonary complications of sickle cell disease: role of nitric oxide and hemolytic anemia.Hematopoietic cell transplantation for sickle cell disease: state of the art.Sickle cell disease in North Europe.Abnormal pulmonary function in adults with sickle cell anemiaPulmonary hypertension associated with sickle cell disease: pathophysiology and rationale for treatment.Sickle-cell disease in Malawian children is associated with restrictive spirometry: a cross-sectional survey.Intensive care unit management of patients with severe pulmonary hypertension and right heart failure.Proteinuria is associated with elevated tricuspid regurgitant jet velocity in children with sickle cell disease.Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.Atherosclerosis in sickle cell disease - a review.Pulmonary endarterectomy is effective and safe in patients with haemoglobinopathies and abnormal red blood cells: the Papworth experience.Antibiotics for treating community-acquired pneumonia in people with sickle cell disease.Clinical and electrocardiographic evaluation of sickle-cell anaemia patients with pulmonary hypertension.Symptomatic pulmonary hypertension in a child with sickle cell disease.Under-recognized complications in patients with paroxysmal nocturnal haemoglobinuria: raised pulmonary pressure and reduced right ventricular function.Placenta growth factor mediated gene regulation in sickle cell disease.Pathways to pulmonary hypertension in sickle cell disease: the search for prevention and early intervention.Quality of sleep and pulmonary function in clinically stable adolescents with sickle cell anemia.Guidelines on red cell transfusion in sickle cell disease Part II: indications for transfusion.Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.
P2860
Q24197977-81F98CC9-2F46-4CBA-82D1-C51E9CE26236Q24245077-520791E8-4FC1-48BB-926B-DDF274A8E2AFQ24606163-1C252120-6936-41DE-9AB9-AB3747BB5B1FQ28512770-7D339445-7393-4A82-B039-26996B1355D1Q34451512-FBE01644-4BE1-4B61-9F76-DB922F054501Q34579250-1D785552-254E-4747-A792-3F17CB3B9B20Q34782494-AB71067B-991C-4047-992F-C9ED49EA56C1Q34806446-DEC0771F-5FF3-4972-BEB6-FD15D651D0BCQ34898802-111A6A39-C483-4C58-9977-061598709B45Q34992760-E6F69111-11A4-4783-BF0D-1A5B14D9FEF4Q35243386-35BBB7A3-9A7A-44C5-B40E-4871BB692EA1Q35590733-4C606F88-B3F2-431E-AB3D-17B089FF6CCCQ35750972-B7D6853B-3873-4CCB-B867-6AD97FC15AB2Q35990633-D492B760-2B8B-4420-9238-0382678A9A9DQ36013070-FC9DF1C4-08CA-48DF-9233-871BC4422D1EQ36120873-8D07CA67-1F18-4333-B08D-FE7F1BC6CEBBQ36330543-C1E51E3F-0992-48F8-8457-83EF763B19DCQ36419650-E704491F-FC95-46D4-B17D-C8E524F13F70Q36717337-92BA6AC6-2860-40DF-9CCE-C9114FC9514AQ36762093-BCAFA088-E848-4C5A-A11D-F7EC9741AA30Q37144500-5164E1B4-4B74-4241-89E4-6CE94F610184Q37159329-A50EA5D0-AE3E-416C-B485-0AB3975D011EQ37303958-01A41C04-291C-4E31-A3FE-D45F5C707BFCQ37893845-3F1F93D1-7033-464A-9E33-7EF3801D99E0Q37944597-67011EF8-C2A1-4916-8EC8-858CC11630B3Q37969631-52F54C61-AE72-4052-982C-B5020CA86B49Q38000155-58492FDD-659F-4912-912C-80BAF20A2054Q38778713-D88FF2A9-82CB-47C3-9F71-D4E98B8443ABQ39007637-A7DD093D-6FB8-4ACB-9591-A5B5157F0EAEQ42125644-53DD862F-2928-452C-B78A-0476392D4454Q42783868-70B5CA93-5E3F-4A12-BB9B-567AA5C975DCQ45085693-B4F6D385-758E-4EDC-932A-AA386E03053AQ46063095-B5DAD621-367C-4B0A-AD4D-38D4D29754D7Q47799282-EBC74E95-8231-49E9-93C3-27038F826154Q48455656-DAB40B2B-3876-4E80-BDC6-7A4648D9F391Q50223743-25B22C63-9C91-47E0-9645-F63DB045E340Q53615283-65065F07-3649-4EB7-BE66-20C8EBBB0BD8
P2860
Chronic sickle cell lung disease: new insights into the diagnosis, pathogenesis and treatment of pulmonary hypertension.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Chronic sickle cell lung disea ...... ent of pulmonary hypertension.
@ast
Chronic sickle cell lung disea ...... ent of pulmonary hypertension.
@en
type
label
Chronic sickle cell lung disea ...... ent of pulmonary hypertension.
@ast
Chronic sickle cell lung disea ...... ent of pulmonary hypertension.
@en
prefLabel
Chronic sickle cell lung disea ...... ent of pulmonary hypertension.
@ast
Chronic sickle cell lung disea ...... ent of pulmonary hypertension.
@en
P2860
P1476
Chronic sickle cell lung disea ...... ent of pulmonary hypertension.
@en
P2093
Roberto F Machado
P2860
P304
P356
10.1111/J.1365-2141.2005.05432.X
P407
P577
2005-05-01T00:00:00Z